Togashi K - Search Results

1

FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.

Higashi T, Hatano E, Ikai I, Nishii R, Nakamoto Y, Ishizu K, Suga T, Kawashima H, Togashi K, Seo S, Kitamura K, Takada Y, Uemoto S. Higashi T, et al. Among authors: togashi k. Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):468-82. doi: 10.1007/s00259-009-1284-9. Epub 2009 Oct 17. Eur J Nucl Med Mol Imaging. 2010. PMID: 19838700

2

Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.

Fujimoto R, Higashi T, Nakamoto Y, Hara T, Lyshchik A, Ishizu K, Kawashima H, Kawase S, Fujita T, Saga T, Togashi K. Fujimoto R, et al. Among authors: togashi k. Ann Nucl Med. 2006 Jul;20(6):399-408. doi: 10.1007/BF03027375. Ann Nucl Med. 2006. PMID: 16922468

3

Clinical value of image fusion from MR and PET in patients with head and neck cancer.

Nakamoto Y, Tamai K, Saga T, Higashi T, Hara T, Suga T, Koyama T, Togashi K. Nakamoto Y, et al. Among authors: togashi k. Mol Imaging Biol. 2009 Jan-Feb;11(1):46-53. doi: 10.1007/s11307-008-0168-x. Epub 2008 Sep 4. Mol Imaging Biol. 2009. PMID: 18769975

4

Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging?

Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T, Ishizu K, Kawashima H, Kawase S, Matsumoto K, Togashi K. Hara T, et al. Among authors: togashi k. Ann Nucl Med. 2009 Sep;23(7):657-69. doi: 10.1007/s12149-009-0288-7. Epub 2009 Aug 7. Ann Nucl Med. 2009. PMID: 19662347

5

The potential clinical value of FDG-PET for recurrent renal cell carcinoma.

Nakatani K, Nakamoto Y, Saga T, Higashi T, Togashi K. Nakatani K, et al. Among authors: togashi k. Eur J Radiol. 2011 Jul;79(1):29-35. doi: 10.1016/j.ejrad.2009.11.019. Epub 2009 Dec 16. Eur J Radiol. 2011. PMID: 20015602 Free article.

6

Inhomogeneous bone marrow uptake caused by G-CSF mimics multiple bone metastases on FDG-PET.

Nakamoto Y, Suga T, Hara T, Ishizu K, Togashi K. Nakamoto Y, et al. Among authors: togashi k. Clin Nucl Med. 2010 Feb;35(2):74-6. doi: 10.1097/RLU.0b013e3181c7bf4e. Clin Nucl Med. 2010. PMID: 20090448

7

Prevalence of positive FDG-PET findings in patients with high CEA levels.

Suga T, Nakamoto Y, Saga T, Higashi T, Hara T, Ishizu K, Nishizawa H, Togashi K. Suga T, et al. Among authors: togashi k. Ann Nucl Med. 2010 Jul;24(6):433-9. doi: 10.1007/s12149-010-0387-5. Epub 2010 Jun 11. Ann Nucl Med. 2010. PMID: 20544325

8

F-18 FDG PET of foreign body granuloma: pathologic correlation with imaging features in 3 cases.

Miyake KK, Nakamoto Y, Mikami Y, Ishizu K, Saga T, Higashi T, Togashi K. Miyake KK, et al. Among authors: togashi k. Clin Nucl Med. 2010 Nov;35(11):853-7. doi: 10.1097/RLU.0b013e3181f483da. Clin Nucl Med. 2010. PMID: 20940541

9

Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases.

Higashi T, Nishii R, Yamada S, Nakamoto Y, Ishizu K, Kawase S, Togashi K, Itasaka S, Hiraoka M, Misaki T, Konishi J. Higashi T, et al. Among authors: togashi k. J Nucl Med. 2011 May;52(5):683-9. doi: 10.2967/jnumed.110.081059. Epub 2011 Apr 15. J Nucl Med. 2011. PMID: 21498534 Free article.

10

Clinical value of FDG-PET for preoperative evaluation of endometrial cancer.

Suga T, Nakamoto Y, Saga T, Higashi T, Hamanaka Y, Tatsumi M, Hayashida K, Hara T, Konishi I, Fujii S, Togashi K. Suga T, et al. Among authors: togashi k. Ann Nucl Med. 2011 May;25(4):269-75. doi: 10.1007/s12149-011-0474-2. Epub 2011 Mar 9. Ann Nucl Med. 2011. PMID: 21547477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,021 results

Search Page

Filters